Theranica’s Nerivio Migra (NM) is a first-of-its kind device for the acute treatment of migraine.
The product is planned to be launched initially in the US an EU during H2/2018 after receiving the proper clearances from the FDA and CE marks, respectively.
Mobile application serves as an integral,
comprehensive part of the product. It serves as “migraine controlling function”: monitoring, reporting and treatment.
The onboarding screens are the first things that the users see when they launch our application.
We use it to demonstrate the information like:
Symptoms screen:
Allows the users to record/adjust their personalized symptoms of their migraine episodes, what are his/her most troublesome symptoms, including the pain level at the start of the migraine.
Treatment screen:
Allows the users:
1. Start, monitor or abort an ongoing treatment
2. Increase or decrease the intensity of the stimulation
3.Before starting a treatment, choose the desired treatment program
